Sumitomo Dainippon, Akorn deal

Akorn purchased Xopenex levalbuterol inhalation solution from Sumitomo’s Sunovion Pharmaceuticals Inc. U.S. subsidiary for $45 million in cash. The single isomer of albuterol is approved in the U.S. ...